The market size of artificial intelligence in healthcare was valued at $10.4 billion in 2021. As diverse applications in healthcare and life science are validated and adopted by healthcare and life science organizations, the hope is that more of these technologies will be integrated.
AI in healthcare is just one component of the content at the MedCity INVEST conference scheduled for March 28-30 at the Ritz Carlton hotel in Chicago — our first in-person event in over 2 years! The event attracts traditional and strategic investors and healthcare executives across providers, payers, big tech, medtech and startups with compelling content and networking opportunities. The event is held in collaboration with Mid-America Healthcare Investors Network (MHIN).
To view the full agenda, click here.
AI comes of age during Covid
Often dismissed as overhyped, artificial intelligence applications matured during the pandemic. Providers relied on conversational AI and other tools to triage patients and communicate with them during the height of Covid-19. Separately huge leaps were made in algorithms helping to diagnose diseases as well. What are the lessons learned about how AI can be leveraged effectively and what are the challenges that must be overcome in scaling these technologies for better outcomes.
Among the speakers so far are:
- Arundhati Parmar, VP & Editor-in-Chief, MedCity News (moderator)
- Dr. Rajarshi Banerjee, CEO, Perspectum
- David Rhew, MD, Global Chief Medical Officer & Vice President of Healthcare, Microsoft
Additionally, the conference will spotlight will be our annual startup pitch contest with four tracks including: PharmaTech, Diagnostics 2.0, Care coordination and value-based care, and Remote Patient Monitoring and Smart Devices. There will also be networking opportunities, including a reception with the incubator MATTER.
Featured Photo: metamorworks, Getty Images
